# DuplexSeq

Type: Technology

Source: Startup Intelligence Brief — https://getstartupbrief.com/entity/duplexseq
Canonical HTML page: https://getstartupbrief.com/entity/duplexseq

## Recent coverage (1 stories)

### Scantox Bolsters Genetic Toxicology Portfolio with TwinStrand Acquisition
2026-02-26 11:32:37 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Scantox has acquired the DuplexSeq™ nonclinical genomics safety business from TwinStrand Biosciences, integrating ultra-sensitive DNA sequencing technology into its preclinical CRO services. The move positions Scantox as a leader in high-precision genetic toxicology, offering pharmaceutical clients 10,000x greater sensitivity in identifying mutagenic risks.
Full story: https://getstartupbrief.com/story/scantox-acquires-twinstrand-duplexseq-genomics

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getstartupbrief.com/guides/methodology for the full editorial methodology.